pbs_code
stringclasses
390 values
drug
stringclasses
18 values
brand
stringclasses
32 values
formulation
stringclasses
38 values
indication
stringclasses
8 values
treatment_phase
stringclasses
57 values
streamlined_code
float64
9.19k
16.9k
online_application
bool
2 classes
authority_method
stringclasses
2 values
hospital_type
stringclasses
3 values
maximum_prescribable_pack
float64
1
5
maximum_quantity_units
float64
1
180
number_of_repeats
float64
0
6
schedule_code
stringdate
2025-07-01 00:00:00
2025-08-01 00:00:00
schedule_year
int64
2.03k
2.03k
schedule_month
stringclasses
2 values
10905Y
Certolizumab pegol
Cimzia
Injection 200 mg in 1 mL single use pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
10906B
Secukinumab
Cosentyx
Injection 150 mg in 1 mL pre-filled pen
ankylosing spondylitis
Continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
10906B
Secukinumab
Cosentyx
Injection 150 mg in 1 mL pre-filled pen
ankylosing spondylitis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
10909E
Certolizumab pegol
Cimzia
Injection 200 mg in 1 mL single use pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
10909E
Certolizumab pegol
Cimzia
Injection 200 mg in 1 mL single use pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
10909E
Certolizumab pegol
Cimzia
Injection 200 mg in 1 mL single use pre-filled syringe
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
10951J
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
4
3
2025-07
2,025
JULY
10951J
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
4
3
2025-07
2,025
JULY
10951J
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
4
3
2025-07
2,025
JULY
10951J
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
4
3
2025-07
2,025
JULY
10954M
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
4
5
2025-07
2,025
JULY
10954M
Tocilizumab
Actemra Subcutaneous Injection
Injection 162 mg in 0.9 mL single use pre-filled syringe
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
4
5
2025-07
2,025
JULY
11196G
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11196G
Etanercept
Enbrel
Injections 50 mg in 1 mL single use pre-filled syringes, 4
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11197H
Etanercept
Enbrel
Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
2
2
5
2025-07
2,025
JULY
11198J
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11198J
Etanercept
Enbrel
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11198J
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11198J
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11198J
Etanercept
Enbrel
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11198J
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11201M
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11201M
Etanercept
Enbrel
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11201M
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11202N
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Subsequent continuing treatment
16,778
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11202N
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
psoriatic arthritis
Subsequent continuing treatment
16,778
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11204Q
Etanercept
Enbrel
Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
2
2
5
2025-07
2,025
JULY
11207W
Etanercept
Enbrel
Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
2
2
5
2025-07
2,025
JULY
11207W
Etanercept
Enbrel
Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
2
2
5
2025-07
2,025
JULY
11208X
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11208X
Etanercept
Enbrel
Injections 50 mg in 1 mL single use pre-filled syringes, 4
psoriatic arthritis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11208X
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11208X
Etanercept
Enbrel
Injections 50 mg in 1 mL single use pre-filled syringes, 4
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11211C
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11211C
Etanercept
Enbrel
Injections 50 mg in 1 mL single use pre-filled syringes, 4
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11215G
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
First continuing treatment
14,683
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11215G
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
First continuing treatment
14,683
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11215G
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
Subsequent continuing treatment
14,701
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11215G
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
ankylosing spondylitis
Subsequent continuing treatment
14,701
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11216H
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
psoriatic arthritis
Subsequent continuing treatment
16,778
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11217J
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
ankylosing spondylitis
First continuing treatment
14,683
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11217J
Etanercept
Brenzys
Injections 50 mg in 1 mL single use pre-filled syringes, 4
ankylosing spondylitis
Subsequent continuing treatment
14,701
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11218K
Etanercept
Brenzys
Injection 50 mg in 1 mL single use auto-injector, 4
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11218K
Etanercept
Enbrel
Injection 50 mg in 1 mL single use auto-injector, 4
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11218K
Etanercept
Nepexto
Injection 50 mg in 1 mL single use auto-injector, 4
rheumatoid arthritis
Subsequent continuing treatment
14,499
true
STREAMLINED
Any
1
1
5
2025-07
2,025
JULY
11318Q
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
2
2025-07
2,025
JULY
11319R
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11319R
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11319R
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11320T
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11320T
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
ankylosing spondylitis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11321W
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
2
2025-07
2,025
JULY
11322X
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11322X
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11322X
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11323Y
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11323Y
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11323Y
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
3
6
0
2025-07
2,025
JULY
11324B
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11324B
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11325C
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11325C
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
5
2025-07
2,025
JULY
11326D
Certolizumab pegol
Cimzia
Solution for injection 200 mg in 1 mL pre-filled pen
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
2
2
2025-07
2,025
JULY
11361Y
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11361Y
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11361Y
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11361Y
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11365E
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11365E
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11365E
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11365E
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11372M
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11372M
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11372M
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11372M
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
3
2025-07
2,025
JULY
11373N
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11373N
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
psoriatic arthritis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11375Q
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11375Q
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11376R
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11376R
Golimumab
Simponi
Injection 50 mg in 0.5 mL single use pre-filled pen
ankylosing spondylitis
Continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
1
5
2025-07
2,025
JULY
11437Y
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11437Y
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11437Y
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11437Y
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11442F
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
28
5
2025-07
2,025
JULY
11442F
Baricitinib
Olumiant
Tablet 2 mg
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
28
5
2025-07
2,025
JULY
11443G
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
First continuing treatment
null
false
AUTHORITY_REQUIRED
Any
1
28
5
2025-07
2,025
JULY
11443G
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
First continuing treatment - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
28
5
2025-07
2,025
JULY
11447L
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
Initial treatment - Initial 1 (new patient)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11447L
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11447L
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
null
false
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11447L
Baricitinib
Olumiant
Tablet 4 mg
rheumatoid arthritis
Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply
null
true
AUTHORITY_REQUIRED
Any
1
28
3
2025-07
2,025
JULY
11482H
Infliximab
Inflectra
Powder for I.V. infusion 100 mg
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Public
1
1
0
2025-07
2,025
JULY
11482H
Infliximab
Renflexis
Powder for I.V. infusion 100 mg
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Public
1
1
0
2025-07
2,025
JULY
11482H
Infliximab
Remicade
Powder for I.V. infusion 100 mg
ankylosing spondylitis
Subsequent continuing treatment
null
false
AUTHORITY_REQUIRED
Public
1
1
0
2025-07
2,025
JULY
11483J
Infliximab
Inflectra
Powder for I.V. infusion 100 mg
rheumatoid arthritis
Subsequent continuing treatment
14,505
true
STREAMLINED
Private
3
3
2
2025-07
2,025
JULY
11483J
Infliximab
Renflexis
Powder for I.V. infusion 100 mg
rheumatoid arthritis
Subsequent continuing treatment
14,505
true
STREAMLINED
Private
3
3
2
2025-07
2,025
JULY
11483J
Infliximab
Remicade
Powder for I.V. infusion 100 mg
rheumatoid arthritis
Subsequent continuing treatment
14,505
true
STREAMLINED
Private
3
3
2
2025-07
2,025
JULY
11486M
Infliximab
Inflectra
Powder for I.V. infusion 100 mg
ankylosing spondylitis
First continuing treatment
14,683
true
STREAMLINED
Public
5
5
3
2025-07
2,025
JULY